Astera Labs Statistics
Total Valuation
Astera Labs has a market cap or net worth of $49.04 billion. The enterprise value is $47.83 billion.
| Market Cap | 49.04B |
| Enterprise Value | 47.83B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astera Labs has 173.49 million shares outstanding. The number of shares has increased by 7.76% in one year.
| Current Share Class | 173.49M |
| Shares Outstanding | 173.49M |
| Shares Change (YoY) | +7.76% |
| Shares Change (QoQ) | +1.21% |
| Owned by Insiders (%) | 10.00% |
| Owned by Institutions (%) | 74.46% |
| Float | 155.79M |
Valuation Ratios
The trailing PE ratio is 139.23 and the forward PE ratio is 50.37. Astera Labs's PEG ratio is 0.96.
| PE Ratio | 139.23 |
| Forward PE | 50.37 |
| PS Ratio | 40.80 |
| Forward PS | 18.71 |
| PB Ratio | 28.41 |
| P/TBV Ratio | 30.01 |
| P/FCF Ratio | 177.23 |
| P/OCF Ratio | 146.06 |
| PEG Ratio | 0.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 167.58, with an EV/FCF ratio of 172.86.
| EV / Earnings | 129.44 |
| EV / Sales | 39.79 |
| EV / EBITDA | 167.58 |
| EV / EBIT | 174.91 |
| EV / FCF | 172.86 |
Financial Position
The company has a current ratio of 10.05, with a Debt / Equity ratio of 0.03.
| Current Ratio | 10.05 |
| Quick Ratio | 9.16 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.16 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.83% and return on invested capital (ROIC) is 62.97%.
| Return on Equity (ROE) | 25.83% |
| Return on Assets (ROA) | 10.67% |
| Return on Invested Capital (ROIC) | 62.97% |
| Return on Capital Employed (ROCE) | 15.47% |
| Weighted Average Cost of Capital (WACC) | 25.37% |
| Revenue Per Employee | $1.59M |
| Profits Per Employee | $488,749 |
| Employee Count | 756 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 3.47 |
Taxes
| Income Tax | -47.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.83% in the last 52 weeks. The beta is 3.84, so Astera Labs's price volatility has been higher than the market average.
| Beta (5Y) | 3.84 |
| 52-Week Price Change | +57.83% |
| 50-Day Moving Average | 347.43 |
| 200-Day Moving Average | 219.79 |
| Relative Strength Index (RSI) | 40.80 |
| Average Volume (20 Days) | 4,457,636 |
Short Selling Information
The latest short interest is 9.11 million, so 5.25% of the outstanding shares have been sold short.
| Short Interest | 9.11M |
| Short Previous Month | 9.53M |
| Short % of Shares Out | 5.25% |
| Short % of Float | 5.85% |
| Short Ratio (days to cover) | 1.95 |
Income Statement
In the last 12 months, Astera Labs had revenue of $1.20 billion and earned $369.49 million in profits. Earnings per share was $2.03.
| Revenue | 1.20B |
| Gross Profit | 903.00M |
| Operating Income | 273.45M |
| Pretax Income | 322.02M |
| Net Income | 369.49M |
| EBITDA | 285.40M |
| EBIT | 273.45M |
| Earnings Per Share (EPS) | $2.03 |
Balance Sheet
The company has $1.25 billion in cash and $44.41 million in debt, with a net cash position of $1.21 billion or $6.97 per share.
| Cash & Cash Equivalents | 1.25B |
| Total Debt | 44.41M |
| Net Cash | 1.21B |
| Net Cash Per Share | $6.97 |
| Equity (Book Value) | 1.73B |
| Book Value Per Share | 9.95 |
| Working Capital | 1.49B |
Cash Flow
In the last 12 months, operating cash flow was $335.71 million and capital expenditures -$59.04 million, giving a free cash flow of $276.68 million.
| Operating Cash Flow | 335.71M |
| Capital Expenditures | -59.04M |
| Depreciation & Amortization | 11.95M |
| Net Borrowing | n/a |
| Free Cash Flow | 276.68M |
| FCF Per Share | $1.59 |
Margins
Gross margin is 75.13%, with operating and profit margins of 22.75% and 30.74%.
| Gross Margin | 75.13% |
| Operating Margin | 22.75% |
| Pretax Margin | 26.79% |
| Profit Margin | 30.74% |
| EBITDA Margin | 23.75% |
| EBIT Margin | 22.75% |
| FCF Margin | 23.02% |
Dividends & Yields
Astera Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.76% |
| Shareholder Yield | -7.76% |
| Earnings Yield | 0.75% |
| FCF Yield | 0.56% |
Analyst Forecast
The average price target for Astera Labs is $389.95, which is 37.96% higher than the current price. The consensus rating is "Buy".
| Price Target | $389.95 |
| Price Target Difference | 37.96% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 65.06% |
| EPS Growth Forecast (3Y) | 63.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astera Labs has an Altman Z-Score of 93.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 93.2 |
| Piotroski F-Score | 4 |